Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets. Promising ne...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
Σειρά: | Progress in Inflammation Research
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Preface
- Targeted drug delivery
- I. Bispecific antibodies
- II. Targeting neovessels with NGR peptides
- Genomic-based drugs
- III. Micro-RNA/aptamers
- Nanomedicine
- IV. Exosomes
- V. Microparticles
- Cross-functional targets
- VI. Metabolic targets in inflammation
- VII. Targeting gut microbiome-immune system interactions
- VIII. Targeting the nervous system as an add on therapy for autoinflammatory conditions
- Biomarkers
- IX. Biomarkers in drug discovery
- Other therapies
- X. Stem cell therapy in the treatment of rheumatic disease and application in the treatment of systemic lupus erythematosus.